Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Leonard Verhagen Metman"'
Autor:
Michael P. Trevarrow, Miranda J. Munoz, Yessenia M. Rivera, Rishabh Arora, Quentin H. Drane, Gian D. Pal, Leonard Verhagen Metman, Lisa C. Goelz, Daniel M. Corcos, Fabian J. David
Publikováno v:
Physiological Reports, Vol 12, Iss 17, Pp n/a-n/a (2024)
Abstract The motor impairments experienced by people with Parkinson's disease (PD) are exacerbated during memory‐guided movements. Despite this, the effect of antiparkinson medication on memory‐guided movements has not been elucidated. We evaluat
Externí odkaz:
https://doaj.org/article/5927c8ff3ac64e1ca8f1c1bb4643c685
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/8d5853014de142dc8dee0869d8f90843
Autor:
Avram Fraint, Bichun Ouyang, Leonard Verhagen Metman, Carolyn Jones, Deborah A. Hall, Karen Marder, Gian Pal
Publikováno v:
Parkinson's Disease, Vol 2019 (2019)
Objectives. As genetic testing is becoming more widely commercially available for Parkinson’s disease (PD) and may have implications regarding clinical outcomes for deep brain stimulation (DBS) and other therapies, we aimed to determine patient kno
Externí odkaz:
https://doaj.org/article/793004dd5bc44795b45aa392d9077f86
Autor:
Fabian J. David, Yessenia M. Rivera, Tara K. Entezar, Rishabh Arora, Quentin H. Drane, Miranda J. Munoz, Joshua M. Rosenow, Sepehr B. Sani, Gian D. Pal, Leonard Verhagen-Metman, Daniel M. Corcos
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Memory-guided movements, vital to daily activities, are especially impaired in Parkinson's disease (PD). However, studies examining the effects of how information is encoded in memory and the effects of common treatments of PD, such as medication and
Externí odkaz:
https://doaj.org/article/775d1f2a0a954a86bce07ffcb06b2a90
Autor:
Ahmad Almelegy, Srujanesh Gunda, Steve Buyske, Marc Rosenbaum, Sepehr Sani, Mitra Afshari, Leonard Verhagen Metman, Christopher Goetz, Deborah Hall, M. Mouradian, Gian Pal
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92387ae0188e2cd5669d3924259afed7
https://doi.org/10.1212/wnl.0000000000202514
https://doi.org/10.1212/wnl.0000000000202514
Autor:
Jason Aldred, Theresa Zesiewicz, Michael Okun, Juan Ramirez Castaneda, Leonard Verhagen Metman, Corneliu Luca, Ritesh Ramdhani, Jennifer Durphy, Yarema Bezchlibnyk, Jonathan Carlson, Kelly Foote, Sepehr Sani, Alexander Papanastassiou, Jonathan Jagid, David Weintraub, Julie Pilitsis, Lilly Chen, Roshini Jain
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a55c181444a72af9f30d320d1d9ea463
https://doi.org/10.1212/wnl.0000000000201900
https://doi.org/10.1212/wnl.0000000000201900
Autor:
Michael Okun, Kelly Foote, Theresa Zesiewicz, Yarema Bezchlibnyk, Alexander Papanastassiou, Jonathan Carlson, Jason Aldred, Vibhor Krishna, Aristide Merola, Corneliu Luca, Jonathan Jagid, Jennifer Durphy, Leonard Verhagen Metman, Sepehr Sani, Steven Ojemann, Drew Kern, David Weintraub, Ritesh Ramdhani, Abdolreza Siadati, Bharathy Sundaram, Cong Zhi Zhao, Derek Martinez, Mustafa Siddiqui, Stephen Tatter, Lilly Chen, Roshini Jain
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a199087dd0c812127a34854e37144e1e
https://doi.org/10.1212/wnl.0000000000201935
https://doi.org/10.1212/wnl.0000000000201935
Autor:
Olivier Rascol, Lars Tönges, Tina deVries, Mark Jaros, Adrian Quartel, David Jacobs, Jean-Philippe Azulay, Ernest Balaguer, Perminder Bhatia, Ivan Bodis-Wollner, Paul Brownstone, Nicolas Boulloche, Gerald J. Calegan, Giovanni Castelnovo, Kelvin L. Chou, Jean-Christophe Corvol, Fabio Danisi, Luc Defebvre, Lydia Vela Desojo, Franck Durif, Reinhard Ehret, Bradley K. Evans, Concetta Forchetti, Joseph H. Friedman, Wolfgang Fogel, Matilde Calopa Garniga, Ramon A. Gil, Paul L. Ginsberg, Mark R. Glasberg, Alida Griffith, Jeffrey W. Groves, Mark Gudesblatt, Neal Hermanowicz, Maria A. Herrera, Jean-Luc Houeto, Robert M. Hutchman, Stuart H. Isaacson, Singar Jagadeesan, Mandar Jog, Andrew Keegan, Fabian Klostermann, Pierre Krystkowiak, Jaime Kulisevsky Bojarsky, Rajeev Kumar, Dennis Lacey, Bruce Lasker, John LaVaccare, Michelle M. Lavallee, Maria Rosario Luquin Piudo, Andreas Mahler, Maria José Martí Domenech, Juan Carlos Martinez Castrillo, Laszlo J. Mate, Tilak Mendis, Leonard Verhagen Metman, Siegfried Martin Muhlack, Thomas Müller, Ariane Park, James Patton, Elizabeth Peckham, Francisco Grandas Pérez, Marcie Rabin, Gerd Reifschneider, Philippe Remy, Pablo Mir Rivera, Johannes Schwarz, Isabelle Roullet-Solignac, Gabriel Salazar, Stephen M. Sergay, Scott Sherman, Richard Shubin, Lorraine Spikol, Frank Steigerwald, Daniel D. Truong, Antonio Ugarte, Francisco Vivancos Matellano, Arnold Witte, Theresa Zesiewicz, Sarah Elizabeth Zauber
Publikováno v:
Parkinsonismrelated disorders. 96
Immediate-release (IR) amantadine has been used for treatment of levodopa induced dyskinesia (LID). The immediate-release/extended-release (IR/ER) amantadine formulation OS320 (OSMOLEX ER®) contains an IR outer layer and ER core for once-daily dosin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e400f18e2a2737bd0b1b24fdaa997460
https://pubmed.ncbi.nlm.nih.gov/35227940
https://pubmed.ncbi.nlm.nih.gov/35227940
Autor:
Pavnit Kukreja, Fahd Amjad, Danish Bhatti, Leonard Verhagen Metman, Odinachi Oguh, Thomas L. Davis, Jorge Zamudio, Rajesh Pahwa
Publikováno v:
Advances in Therapy
In 2015, the US Food and Drug Administration approved levodopa-carbidopa intestinal gel (LCIG; also known as carbidopa-levodopa enteral suspension in the US) for the treatment of motor fluctuations in patients with advanced Parkinson’s disease. LCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c7c45959a72dafe6b1387310891628
https://doi.org/10.1007/s12325-019-01014-4
https://doi.org/10.1007/s12325-019-01014-4
Autor:
Nadine Knowles, John G. Nutt, Laura E. Pope, Stewart A. Factor, Anthony E. Lang, Joao Siffert, Susan H. Fox, Leonard Verhagen Metman, Matthew Brodsky
Publikováno v:
Movement Disorders. 32:893-903
Background: Nondopaminergic pathways represent potential targets to treat levodopa-induced dyskinesia in Parkinson's disease (PD). This pilot-study (NCT01767129) examined the safety/efficacy of the sigma-1 receptor-agonist and glutamatergic/monoamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7401becf55a310ad9e35f1847601ef5
https://doi.org/10.1002/mds.26976
https://doi.org/10.1002/mds.26976